Surgical outcomes of total duct excision in the diagnosis and management of nipple discharge
CONCLUSIONS: TDE can be considered for the diagnostics and management of nipple discharge. Blood-stained nipple discharge increases the risk of DCIS or malignancy, but the majority of the time TDE reveals benign breast pathology.PMID:38497796 | DOI:10.1308/rcsann.2022.0093 (Source: Annals of the Royal College of Surgeons of England)
Source: Annals of the Royal College of Surgeons of England - March 18, 2024 Category: Surgery Authors: K Ward G Selvarajah H Al-Omishy M Sait H N Khan K McEvoy S Robertson Source Type: research
Surgical outcomes of total duct excision in the diagnosis and management of nipple discharge
CONCLUSIONS: TDE can be considered for the diagnostics and management of nipple discharge. Blood-stained nipple discharge increases the risk of DCIS or malignancy, but the majority of the time TDE reveals benign breast pathology.PMID:38497796 | DOI:10.1308/rcsann.2022.0093 (Source: Annals of the Royal College of Surgeons of England)
Source: Annals of the Royal College of Surgeons of England - March 18, 2024 Category: Surgery Authors: K Ward G Selvarajah H Al-Omishy M Sait H N Khan K McEvoy S Robertson Source Type: research
Surgical outcomes of total duct excision in the diagnosis and management of nipple discharge
CONCLUSIONS: TDE can be considered for the diagnostics and management of nipple discharge. Blood-stained nipple discharge increases the risk of DCIS or malignancy, but the majority of the time TDE reveals benign breast pathology.PMID:38497796 | DOI:10.1308/rcsann.2022.0093 (Source: Annals of the Royal College of Surgeons of England)
Source: Annals of the Royal College of Surgeons of England - March 18, 2024 Category: Surgery Authors: K Ward G Selvarajah H Al-Omishy M Sait H N Khan K McEvoy S Robertson Source Type: research
Surgical outcomes of total duct excision in the diagnosis and management of nipple discharge
CONCLUSIONS: TDE can be considered for the diagnostics and management of nipple discharge. Blood-stained nipple discharge increases the risk of DCIS or malignancy, but the majority of the time TDE reveals benign breast pathology.PMID:38497796 | DOI:10.1308/rcsann.2022.0093 (Source: Annals of the Royal College of Surgeons of England)
Source: Annals of the Royal College of Surgeons of England - March 18, 2024 Category: Surgery Authors: K Ward G Selvarajah H Al-Omishy M Sait H N Khan K McEvoy S Robertson Source Type: research
Surgical outcomes of total duct excision in the diagnosis and management of nipple discharge
CONCLUSIONS: TDE can be considered for the diagnostics and management of nipple discharge. Blood-stained nipple discharge increases the risk of DCIS or malignancy, but the majority of the time TDE reveals benign breast pathology.PMID:38497796 | DOI:10.1308/rcsann.2022.0093 (Source: Annals of the Royal College of Surgeons of England)
Source: Annals of the Royal College of Surgeons of England - March 18, 2024 Category: Surgery Authors: K Ward G Selvarajah H Al-Omishy M Sait H N Khan K McEvoy S Robertson Source Type: research
Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ
CONCLUSION: In a cohort who had DCIS diagnosis before mastectomy and were mostly symptomatic, the upgrade rate was 51.3%. Despite the high upgrade rate, nodal involvement remained comparable. Risk factors could select patients for omission of upfront SLNB, with a delayed SLNB planned if needed.PMID:38458843 | DOI:10.1016/j.clbc.2024.02.002 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Jinnie Pang Zhiyan Yan Qing Ting Tan John C Allen Mingjia Wang Geok Hoon Lim Source Type: research
Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ
CONCLUSION: In a cohort who had DCIS diagnosis before mastectomy and were mostly symptomatic, the upgrade rate was 51.3%. Despite the high upgrade rate, nodal involvement remained comparable. Risk factors could select patients for omission of upfront SLNB, with a delayed SLNB planned if needed.PMID:38458843 | DOI:10.1016/j.clbc.2024.02.002 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Jinnie Pang Zhiyan Yan Qing Ting Tan John C Allen Mingjia Wang Geok Hoon Lim Source Type: research
Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ
Nanomedicine, Ahead of Print. (Source: Future Medicine: Nanomedicine)
Source: Future Medicine: Nanomedicine - March 5, 2024 Category: Nanotechnology Authors: Bharti Mangla Priya Mittal Pankaj Kumar Shamama Javed Waquar Ahsan Geeta Aggarwal Source Type: research
Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ
Nanomedicine, Ahead of Print. (Source: Nanomedicine)
Source: Nanomedicine - March 5, 2024 Category: Nanotechnology Authors: Bharti Mangla Priya Mittal Pankaj Kumar Shamama Javed Waquar Ahsan Geeta Aggarwal Source Type: research
The epidemiological and clinicopathological features of breast cancer in Riyadh, Saudi Arabia
CONCLUSION: In Saudi Arabia, a trend of BC incidence migration towards older patients may be ensuing. However, prediction of an advanced and aggressive presentation requires the enhancement of screening programs and standardized protocols for disease management.PMID:38438204 | DOI:10.15537/smj.2024.45.3.20230656 (Source: Saudi Medical Journal)
Source: Saudi Medical Journal - March 4, 2024 Category: Middle East Health Authors: Ahmad Aa Omer Salman A Bin Dayel Ali Sa Hummedi Noura Ia Almuhaimed Source Type: research
